The molecular mechanism of actin of OATP1B1 and CYP3A4 genetic polymorphism on the metabolism and transport of atorvastatin

YUAN Zhao,LI Xin-hua,HUANG Shi-bo,XIA Chun-hua,XIONG Yu-qing
DOI: https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2013.13.026
2013-01-01
Abstract:OBJECTIVE To study the molecular mechanism of actin of OATP1B1 and CYP3A4 genetic polymorphism in the metabolism and transport of atorvastatin.METHODS Build OATP1B1*1a,*5 and*15 recombinant plasmid model was established to study differences in transport(in vitro) and its molecular mechanism of atorvastatin in different OATP1B1 genotype mutant;and to study the difference in metaboliem and its molecular mechanism of atorvastatin in wild-type and different points mutant CYP3A4 recombinant enzyme.RESULTS The effects of OATP1B1*1a and OATP1B1*5 gene on atorvastatin transport were quite different,OATP1B1*5 gene reduced the transport capacity of atorvastatin.Compared with OATP1B1*15,OATP1B1*5 the transport activity was lower.In our research,the activities of CYP3A4*3 and CYP3A4*5 were greater than the the activity of CYP3A4*16,the activities of CYP3A4*3 and CYP3A4*5 were lower than the wild type,the CYP3A4*18 had the similar activity of wild-type.CONCLUSION Our present results suggest that the OATP1B1 521 site might be the molecular action site of transporting ATV,also be the key affect point of transport capacity of ATV.And CYP3A4*3,CYP3A4 *5,CYP3A4*16 sites may be the molecular role of point of ATV metabolism,also affect CYP3A4 on the the ATV metabolic activity of key sites.Therefore,in clinic the applications should be based on the mutation of OATP1B1 and CYP3A4 to guide the rational use of ATV.
What problem does this paper attempt to address?